Neuronetics Inc. (STIM) Price to Earnings Ratio

Corporate emblem and logo of Neuronetics Inc. (STIM)

Leveraging contract electronics manufacturing and external service logistics, Neuronetics, Inc. (STIM) is developing niche medical technology. This price action chart on GURU.Markets shows a PE ratio of -7.30. Such resilient quotes are supported by the impeccable brand image of NeuroStar in psychiatry, as well as management's savvy strategy to expand insurance reimbursements and maintain control over its market segment.

Neuronetics, Inc (STIM) Price to Earnings Ratio: for the period 07/04/2022 - 11/10/2026

Comprehensive metric breakdowns and analytics for NeuroStar (STIM)

- price and consensus price forecast:
Stock Price neurostar.com|STIM - Price Target Chart
- market capitalization details:
Market Value Neuronetics, Inc.|STIM - Enterprise Value
- book capitalization information:
Net Assets per Share Neuronetics|STIM - Company Net Assets|Market Capitalization to Net Assets neurostar.com|STIM - Company Total Assets
- debt and solvency information:
Debt to Capital Neuronetics, Inc.|STIM - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Neuronetics, Inc|STIM - Company Total Debt|Debt to Net Assets Ratio Neuronetics, Inc.|STIM - Company Long-Term Debt|Company Current Liabilities Neuronetics|Immediate Liquidity neurostar.com
- earnings and market multiples details:
STIM - Net Profit|Net Profit Forecast Neuronetics, Inc.|STIM - P/E Multiple|Market Cap to Projected Earnings Neuronetics Inc.|STIM - PEG Multiple|Enterprise Value to EBITDA Ratio Neuronetics, Inc.|STIM - Operating profit EBITDA|Net earnings per share (EPS TTM) Neuronetics|STIM - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months neurostar.com|STIM - Net earnings per share growth this year|Expected earnings per share trend next year Neuronetics, Inc.
General company analysis:neurostar.com - STIM
Original product of neurostar.com

For Neuronetics, Inc. (STIM), the market capitalization-to-net income ratio reflects the value of each unit of revenue generated from the sale of NeuroStar systems. This coefficient measures the investment payback period, demonstrating a premium for protecting capital against inflation. By analyzing the current price-to-earnings valuation, an investor determines the degree to which the asset is overbought relative to the efficiency of equipment sales to clinics. The stability of this indicator confirms the fundamental resilience of the business within the severe depression therapy segment.

Analysis of competing companies

P/E Multiple bostonscientific.com|Price to Earnings Ratio Edwards Lifesciences Corporation (EW)|Price to Earnings Ratio RMD (ResMed Inc)|P/E Multiple PODD (OmniPod)|Business Payback Period Zimmer Biomet (ZBH)|COO: Price to Earnings Ratio|Market Cap to Net Income ALGN|GMED: P/E Multiple|Market Cap to Earnings TransMedics Organ Care System (TMDX)|ATEC (ATEC Spine) - P/E Multiple|Price to Earnings Multiple AORT (Artivion Corp)|Price to Earnings Ratio ENOV (Enovis Corporation)|IART (integralife.com) - Company Value to Net Income|Price to Earnings Ratio Establishment Labs Holdings Inc. ESTA|BBNX - Price to Earnings Ratio|Iradimed - P/E Multiple|Market Cap to Earnings Embecta Health|TNDM: P/E Multiple|Price to Earnings Multiple AXGN|SIBN (SI-BONE) - P/E Multiple|Orthofix Medical (OFIX) - Business Payback Period|P/E Multiple BVS|Price to Earnings Ratio orthopediatrics.com KIDS|P/E Multiple TMCI (Treace Medical Concepts)|P/E Multiple blade.com SRTA|CARL - Price to Earnings Ratio|RXST: Price to Earnings Ratio|CLPT (clearpointneuro.com) - Price to Earnings Ratio|Stereotaxis Corporation - Company Value to Net Income|SGHT (Sight Sciences, Inc.) - P/E Multiple|Market Cap to Earnings orchestrabiomed.com OBIO|Price to Earnings Ratio Anika Therapeutics (ANIK)|InspireMD Inc (NSPR) - Market Cap to Net Income Ratio|Jin Medical - Price to Earnings Ratio|P/E Multiple Vivani Medical Inc VANI|Xtant Medical Inc - P/E Multiple|Business Payback Period n1mtc.com NMTC|modular-medical.com (MODD) - Price to Earnings Ratio|Market Cap to Net Income MYO (Myomo Inc.)|Price to Earnings Ratio Envoy Medical, Inc|Price to Earnings Ratio Vivos Therapeutics Inc (VVOS)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|INVO Fertility Corp - Market Price to Net Income Ratio|Bone Biologics (BBLG) - Price to Earnings Ratio|Price to Earnings Multiple AXNX|BIOL (BIOLASE) - P/E Multiple|Market Cap to Earnings Dynatronics Corp. DYNT|Price to Earnings Ratio FNA (Paragon 28, Inc.)|P/E Multiple invobioscience.com (INVO)